Endoscopies at Vanderbilt exposed patients to HIV, hepatitis C

Nashville-based Vanderbilt Health is notifying patients that they may have been exposed to hepatitis B, hepatitis C and HIV as a result of botched endoscopy procedures performed at a clinic located on the hospital’s main campus. 

The news comes from WZTV, who interviewed patients who received these terrifying phone calls. For many, the tainted procedures were performed months ago, raising concerns of further spread to friends, family and strangers.

The risk to patients is low, a spokesperson for Vanderbilt said. However, anyone potentially infected is being notified as a precaution. Around 4% of total procedures are linked to potential exposure to viruses. 

A solution used during the procedure is being blamed for the risk of infection, but the state health department is still investigating the incidents. 

“We recently discovered an issue in how a solution was administered through the scope during a limited number of endoscopy procedures at the Vanderbilt Clinic. We immediately corrected the issue and reported it to the Tennessee Department of Health. We are in the process of notifying patients who had an endoscopy procedure and may have been affected,” a Vanderbilt spokesperson said in a statement. 

The exact number of patients impacted has not been revealed. However, according to the report, the number of tainted endoscopies dates back six months. 

Read the full story from WZTV at the link below. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup